Economic evaluation of proton radiation therapy in the treatment of breast cancer.
暂无分享,去创建一个
Ulf Isacsson | Bengt Jönsson | Mattias Ekman | Bengt Glimelius | U. Isacsson | B. Jönsson | B. Glimelius | M. Ekman | Jonas Lundkvist | Suzanne Rehn Ericsson | J. Lundkvist | S. R. Ericsson
[1] U. Isacsson,et al. Potential gains using high-energy protons for therapy of malignant tumours. , 1999, Acta oncologica.
[2] A. Norlund. Costs of Radiotherapy , 2003, Acta oncologica.
[3] N. Zethraeus,et al. [Cost-effectiveness of bisoprolol in chronic heart failure]. , 2002, Lakartidningen.
[4] P. Hall,et al. Mortality from cardiovascular disease more than 10 years after radiotherapy for breast cancer: nationwide cohort study of 90 000 Swedish women , 2003, BMJ : British Medical Journal.
[5] J. Overgaard,et al. Time course of radiological lung density changes after postmastectomy radiotherapy. , 2000, Acta oncologica.
[6] L. Rutqvist,et al. Long-term cardiac morbidity and mortality in a randomized trial of pre- and postoperative radiation therapy versus surgery alone in primary breast cancer. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[7] Harald Paganetti,et al. Proton Beams to Replace Photon Beams in Radical Dose Treatments , 2003, Acta oncologica.
[8] R. Maestri,et al. Cost/utility ratio in chronic heart failure: comparison between heart failure management program delivered by day-hospital and usual care , 2002 .
[9] Radiation Therapy Dose Delivery , 2003, Acta oncologica.
[10] C. la Vecchia,et al. The fall in breast cancer mortality in Europe. , 2001, European journal of cancer.
[11] J. Newhouse. US and UK health economics: two disciplines separated by a common language? , 1998, Health economics.
[12] Ludvig Paul Muren,et al. Cardiac and pulmonary doses and complication probabilities in standard and conformal tangential irradiation in conservative management of breast cancer. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[13] Michael E. Chernew,et al. Willingness to Pay for a Quality-adjusted Life Year , 2000, Medical decision making : an international journal of the Society for Medical Decision Making.
[14] A. Lomax,et al. Potential role of intensity-modulated photons and protons in the treatment of the breast and regional nodes. , 2003, International journal of radiation oncology, biology, physics.
[15] A Ottolenghi,et al. Long-term cardiac mortality after radiotherapy of breast cancer--application of the relative seriality model. , 1996, The British journal of radiology.
[16] E. Jonsson. Studies in health economics , 1980 .
[17] Lawrence B Marks,et al. Myocardial perfusion changes in patients irradiated for left-sided breast cancer and correlation with coronary artery distribution. , 2001, International journal of radiation oncology, biology, physics.
[18] M Goitein,et al. The relative costs of proton and X-ray radiation therapy. , 2003, Clinical oncology (Royal College of Radiologists (Great Britain)).
[19] U. Isacsson,et al. Node-positive left-sided breast cancer patients after breast-conserving surgery: potential outcomes of radiotherapy modalities and techniques. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[20] M. Rosen,et al. Breast cancer mortality in Sweden. , 2002, European journal of cancer.
[21] G. Gyenes. Radiation-induced ischemic heart disease in breast cancer--a review. , 1998, Acta oncologica.
[22] Bengt Brorsson,et al. The Swedish Council on Technology Assessment in Health Care (SBU) Systematic Overview of Radiotherapy for Cancer including a Prospective Survey of Radiotherapy Practice in Sweden 2001--Summary and Conclusions , 2003, Acta oncologica.
[23] Peter Lindgren,et al. A computer model to analyse the cost-effectiveness of hormone replacement therapy - a revised version , 2000 .
[24] R. Jaszczak,et al. Relating radiation-induced regional lung injury to changes in pulmonary function tests. , 2001, International journal of radiation oncology, biology, physics.
[25] G. Stone,et al. Cost-Effectiveness of Coronary Stenting in Acute Myocardial Infarction: Results From the Stent Primary Angioplasty in Myocardial Infarction (Stent-PAMI) Trial , 2001, Circulation.
[26] T. Fornander,et al. A descriptive study of pulmonary complications after postoperative radiation therapy in node-positive stage II breast cancer. , 1997, Acta oncologica.
[27] David O. Meltzer,et al. Editorial: Some reflections on cost‐effectiveness analysis , 1998 .
[28] C. Rose,et al. A Systematic Overview of Radiation Therapy Effects in Breast Cancer , 2003, Acta oncologica.
[29] A Ottolenghi,et al. Radiation pneumonitis after breast cancer irradiation: analysis of the complication probability using the relative seriality model. , 2000, International journal of radiation oncology, biology, physics.
[30] J. Bergh,et al. Pulmonary toxicity after radiotherapy in primary breast cancer patients: results from a randomized chemotherapy study. , 2002, International journal of radiation oncology, biology, physics.
[31] T. Möller,et al. A Prospective Survey of Radiotherapy Practice 2001 in Sweden , 2003, Acta oncologica.
[32] N. Zethraeus,et al. Costs of coronary heart disease and stroke: the case of Sweden , 1999, Journal of internal medicine.
[33] A. Mcguire,et al. Cost-utility of enoxaparin compared with unfractionated heparin in unstable coronary artery disease , 2001, BMC cardiovascular disorders.
[34] M. Rosén,et al. Cancer Survival in Sweden 1960–1998 Developments Across Four Decades , 2003, Acta oncologica.
[35] J. Lebesque,et al. Cardiac and lung complication probabilities after breast cancer irradiation. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[36] J R Beck,et al. Markov Models in Medical Decision Making , 1993, Medical decision making : an international journal of the Society for Medical Decision Making.